Latest Articles
Multimodal physical therapy proves effective for women with chronic pelvic pain - Contemporary Obgyn
Multimodal physical therapy proves effective for women with chronic pelvic pain Contemporary Obgyn
Published: Jan. 6, 2025, 9:51 p.m.
Unveiling Immunogenic Characteristics and Neoantigens in Endometrial Cancer with POLE Hotspot Mutations for Improved Immunotherapy - Frontiers
Unveiling Immunogenic Characteristics and Neoantigens in Endometrial Cancer with POLE Hotspot Mutations for Improved Immunotherapy Frontiers
Published: Jan. 6, 2025, 6:36 p.m.
Machine learning Nomogram for Predicting endometrial lesions after tamoxifen therapy in breast Cancer patients - Nature.com
Machine learning Nomogram for Predicting endometrial lesions after tamoxifen therapy in breast Cancer patients Nature.com
Published: Jan. 6, 2025, 3:49 p.m.
Multiple Subcutaneous Metastases in Endometrial Cancer Treated With Systemic Chemotherapy: A Case Report and Review of the Literature - Cureus
Multiple Subcutaneous Metastases in Endometrial Cancer Treated With Systemic Chemotherapy: A Case Report and Review of the Literature Cureus
Published: Jan. 5, 2025, 6:05 a.m.
Unveiling DNA Methylation: Early Diagnosis, Risk Assessment, and Therapy for Endometrial Cancer - Frontiers
Unveiling DNA Methylation: Early Diagnosis, Risk Assessment, and Therapy for Endometrial Cancer Frontiers
Published: Dec. 30, 2024, 11:50 p.m.
Advantage Healthcare & Physiotherapy Expands Women's Physiotherapy Services - Markets Insider
Advantage Healthcare & Physiotherapy Expands Women's Physiotherapy Services Markets Insider
Published: Dec. 30, 2024, 1:49 p.m.
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - Frontiers
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment Frontiers
Published: Dec. 24, 2024, 7:10 p.m.
Research Bolsters Need for Enhanced Surveillance After Radiotherapy for Endometrial Cancer - Oncology Nurse Advisor
Research Bolsters Need for Enhanced Surveillance After Radiotherapy for Endometrial Cancer Oncology Nurse Advisor
Published: Dec. 23, 2024, 5 p.m.
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today
Published: Dec. 18, 2024, 8:16 p.m.
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - Medpage Today
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer Medpage Today
Published: Dec. 18, 2024, 3:27 p.m.
Link copied to clipboard!